Skip to main content
Erschienen in: Surgical Endoscopy 10/2004

01.10.2004 | Original article

Effects of the aldosterone receptor antagonist potassium canrenoate on renal blood flow and urinary output during prolonged increased intraabdominal pressure (IAP) in pigs

verfasst von: F. F. Gudmundsson, A. Viste, O. L. Myking, K. Grong, K. Svanes

Erschienen in: Surgical Endoscopy | Ausgabe 10/2004

Einloggen, um Zugang zu erhalten

Abstract

Background

Increased intraabdominal pressure can be found after major abdominal trauma and necrotizing pancreatitis and is used during laparoscopic surgery. The purpose of this study was to investigate the effect of the aldosterone receptor antagonist (potassium canrenoate) on renal hemodynamics and urinary output in pigs during increased intraabdominal pressure (IAP).

Methods

The IAP was kept at 30 mmHg for 3 h by instillation of Ringer’s solution into the peritoneal cavity. Eight animals were treated with potassium canrenoate and eight animals served as controls. Renal blood flow, hormones in femoral artery blood, and the urinary output were measured.

Results

The administration of potassium canrenoate was followed by increased aldosterone concentrations in arterial blood, increased blood concentration of potassium, and increased concentration of sodium in the urine, indicating satisfactory inhibition of aldosterone. Potassium canrenoate did not cause changes in cardiac output and arterial pressure. It did not affect the renal vascular resistance that increased at an IAP of 30 mmHg, or the renal blood flow that remained constant during the experiments. The group treated with potassium canrenoate had higher mean urinary output than the controls, but the difference was not significant.

Conclusion

Increased IAP in pigs is associated with markedly reduced urinary output and increased serum concentrations of aldosterone. Although the urinary output did not increase significantly, the increased sodium concentration in the urine of canrenoate-treated animals suggests that the high blood level of aldosterone contributes to the oliguria under increased IAP.
Literatur
1.
Zurück zum Zitat Bloomfield, GL, Blocher, CR, Fakhry, IF, Sica, DA, Sugerman, HJ 1997Elevated intraabdominal pressure increases plasma renin activity and aldosterone levelsJ Trauma429971005PubMed Bloomfield, GL, Blocher, CR, Fakhry, IF, Sica, DA, Sugerman, HJ 1997Elevated intraabdominal pressure increases plasma renin activity and aldosterone levelsJ Trauma429971005PubMed
2.
Zurück zum Zitat Bradley, SE, Bradley, GP 1947The effect of increased intraabdominal pressure renal function in manJ Clin Invest2610101022 Bradley, SE, Bradley, GP 1947The effect of increased intraabdominal pressure renal function in manJ Clin Invest2610101022
3.
Zurück zum Zitat Caldwell, CB, Ricotta, JJ 1987Changes in visceral blood flow with elevated intraabdominal pressureJ Surg Res431420PubMed Caldwell, CB, Ricotta, JJ 1987Changes in visceral blood flow with elevated intraabdominal pressureJ Surg Res431420PubMed
4.
Zurück zum Zitat Caldwell, CB, Ricotta, JJ 1986Evaluation of intraabdominal pressure and renal hemodynamicsCurr Surg43495498PubMed Caldwell, CB, Ricotta, JJ 1986Evaluation of intraabdominal pressure and renal hemodynamicsCurr Surg43495498PubMed
5.
Zurück zum Zitat Coombs, HC 1922The mechanism of the regulation of intraabdominal pressureAm J Physiol61159170 Coombs, HC 1922The mechanism of the regulation of intraabdominal pressureAm J Physiol61159170
6.
Zurück zum Zitat Cullen, DJ, Coyle, JP, Teplick, R, Long, MC 1989Cardiovascular, pulmonary, and renal effects of massively increased intraabdominal pressure in critically ill patientsCrit Care Med17118121PubMed Cullen, DJ, Coyle, JP, Teplick, R, Long, MC 1989Cardiovascular, pulmonary, and renal effects of massively increased intraabdominal pressure in critically ill patientsCrit Care Med17118121PubMed
7.
Zurück zum Zitat Diebel, LN, Wilson, RF, Dulchavsky, SA, Saxe, J 1992Effect of increased intraabdominal pressure on hepatic arterial, portal venous, and hepatic microcirculatory blood flowJ Trauma33279282PubMed Diebel, LN, Wilson, RF, Dulchavsky, SA, Saxe, J 1992Effect of increased intraabdominal pressure on hepatic arterial, portal venous, and hepatic microcirculatory blood flowJ Trauma33279282PubMed
8.
Zurück zum Zitat Gudmundsson, FF, Gislason, HG, Dicko, A, Horn, A, Viste, A, Grong, K, Svanes, K 2001Effects of prolonged increased intraabdominal pressure on gastrointestinal blood flow in pigsSurg Endosc15854860CrossRefPubMed Gudmundsson, FF, Gislason, HG, Dicko, A, Horn, A, Viste, A, Grong, K, Svanes, K 2001Effects of prolonged increased intraabdominal pressure on gastrointestinal blood flow in pigsSurg Endosc15854860CrossRefPubMed
9.
Zurück zum Zitat Gudmundsson, FF, Gislason, HG, Myking, OL, Viste, A, Grong, K, Svanes, K 2002Hormonal changes related to decreased renal blood flow and low urine output under prolonged increased intraabdominal pressure in pigsEur J Surg168178186CrossRefPubMed Gudmundsson, FF, Gislason, HG, Myking, OL, Viste, A, Grong, K, Svanes, K 2002Hormonal changes related to decreased renal blood flow and low urine output under prolonged increased intraabdominal pressure in pigsEur J Surg168178186CrossRefPubMed
10.
Zurück zum Zitat Gudmundsson, FF, Viste, A, Myking, OL, Bostad, L, Grong, K, Svanes, K 2003Role of angiotensin-II under prolonged increased intraabdominal pressure (IAP) in pigsSurg Endosc1710921097CrossRefPubMed Gudmundsson, FF, Viste, A, Myking, OL, Bostad, L, Grong, K, Svanes, K 2003Role of angiotensin-II under prolonged increased intraabdominal pressure (IAP) in pigsSurg Endosc1710921097CrossRefPubMed
11.
Zurück zum Zitat Gunning, ME, Ingelfinger, JR, King, AJ, Brenner, BM 1995Vasoactive peptides and the kidneyBrenner and Rector’s The KidneyWB SaundersPhiladelphia242244 Gunning, ME, Ingelfinger, JR, King, AJ, Brenner, BM 1995Vasoactive peptides and the kidneyBrenner and Rector’s The KidneyWB SaundersPhiladelphia242244
12.
Zurück zum Zitat Harman, PK, Kron, IL, McLachlan, HD, Freedlender, AE, Nolan, SP 1982Elevated intraabdominal pressure and renal functionAnn Surg196594597PubMed Harman, PK, Kron, IL, McLachlan, HD, Freedlender, AE, Nolan, SP 1982Elevated intraabdominal pressure and renal functionAnn Surg196594597PubMed
13.
Zurück zum Zitat Heymann, MA, Payne, BD, Hoffman, JI, Rudolph, AM 1977Blood flow measurements with radionuclide-labelled particlesProg Cardiovasc Dis205579PubMed Heymann, MA, Payne, BD, Hoffman, JI, Rudolph, AM 1977Blood flow measurements with radionuclide-labelled particlesProg Cardiovasc Dis205579PubMed
14.
Zurück zum Zitat Ivankovich, AD, Miletich, DJ, Albrecht, RF, Heyman, HJ, Bonnet, RF 1975Cardiovascular effects of intraperitoneal insufflation with carbon dioxide and nitrous oxide in the dogAnesthesiology42281287PubMed Ivankovich, AD, Miletich, DJ, Albrecht, RF, Heyman, HJ, Bonnet, RF 1975Cardiovascular effects of intraperitoneal insufflation with carbon dioxide and nitrous oxide in the dogAnesthesiology42281287PubMed
15.
Zurück zum Zitat Karim, A 1978Spironolactone: disposition, metabolism, pharmacodynamics and bioavailabilityDrug Metab Rev8151188PubMed Karim, A 1978Spironolactone: disposition, metabolism, pharmacodynamics and bioavailabilityDrug Metab Rev8151188PubMed
16.
Zurück zum Zitat Kashtan, J, Green, JF, Parsons, EQ, Holcroft, JW 1981Hemodynamic effect of increased abdominal pressureJ Surg Res30249255CrossRefPubMed Kashtan, J, Green, JF, Parsons, EQ, Holcroft, JW 1981Hemodynamic effect of increased abdominal pressureJ Surg Res30249255CrossRefPubMed
17.
Zurück zum Zitat Kojima, K, Yamamoto, K, Fujioka, H, Kaneko, H 1985Pharmacokinetics of spironolactone and potassium canrenoate in humansJ Pharmacobiodynam8161166 Kojima, K, Yamamoto, K, Fujioka, H, Kaneko, H 1985Pharmacokinetics of spironolactone and potassium canrenoate in humansJ Pharmacobiodynam8161166
18.
Zurück zum Zitat Krause, W, Karras, J, Seifert, W 1983Pharmacokinetics of canrenone after oral administration of spironolactone and intravenous injection of canrenoate-K in healthy manEur J Clin Pharmacol25449453PubMed Krause, W, Karras, J, Seifert, W 1983Pharmacokinetics of canrenone after oral administration of spironolactone and intravenous injection of canrenoate-K in healthy manEur J Clin Pharmacol25449453PubMed
19.
Zurück zum Zitat Mo, R, Myking, OL, Lund-Johansen, P, Omvik, P 1994The Bergen blood pressure study: in appropriately low levels of circulating atrial natriuretic peptide in offspring of hypertensive familiesBlood Press3223230PubMed Mo, R, Myking, OL, Lund-Johansen, P, Omvik, P 1994The Bergen blood pressure study: in appropriately low levels of circulating atrial natriuretic peptide in offspring of hypertensive familiesBlood Press3223230PubMed
20.
Zurück zum Zitat Richardson, JD, Trinkle, JK 1976Hemodynamic and respiratory alterations with increased intraabdominal pressureJ Surg Res20401404CrossRefPubMed Richardson, JD, Trinkle, JK 1976Hemodynamic and respiratory alterations with increased intraabdominal pressureJ Surg Res20401404CrossRefPubMed
21.
Zurück zum Zitat Saggi, BH, Sugerman, HJ, Ivatury, RR, Bloomfield, GL 1998Abdominal compartment syndromeJ Trauma45597609PubMed Saggi, BH, Sugerman, HJ, Ivatury, RR, Bloomfield, GL 1998Abdominal compartment syndromeJ Trauma45597609PubMed
22.
Zurück zum Zitat Sugrue, M, Buist, MD, Hourihan, F, Deane, S, Bauman, A, Hillman, K 1995Prospective study of intraabdominal hypertension and renal function after laparotomyBr J Surg82235238PubMed Sugrue, M, Buist, MD, Hourihan, F, Deane, S, Bauman, A, Hillman, K 1995Prospective study of intraabdominal hypertension and renal function after laparotomyBr J Surg82235238PubMed
23.
Zurück zum Zitat Wendt, EC 1876Uber den Einfluss des intraabdominalen Druckes auf die Absonderungsgeschwindigkeit des HarnesArch Heilkunde17527 Wendt, EC 1876Uber den Einfluss des intraabdominalen Druckes auf die Absonderungsgeschwindigkeit des HarnesArch Heilkunde17527
Metadaten
Titel
Effects of the aldosterone receptor antagonist potassium canrenoate on renal blood flow and urinary output during prolonged increased intraabdominal pressure (IAP) in pigs
verfasst von
F. F. Gudmundsson
A. Viste
O. L. Myking
K. Grong
K. Svanes
Publikationsdatum
01.10.2004
Erschienen in
Surgical Endoscopy / Ausgabe 10/2004
Print ISSN: 0930-2794
Elektronische ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-003-9295-2

Weitere Artikel der Ausgabe 10/2004

Surgical Endoscopy 10/2004 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.